Concepedia

Raffael Nachbagauer

RN

70

Publications

6.1K

Citations

41

H-Index

2011

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Moderna Therapeutics (United States)

University of Vienna

Program for Appropriate Technology in Health

GlaxoSmithKline (Belgium)

Raffael Nachbagauer is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2011–2025

70

Publications

70

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

Susana V. Bardina, Paul Bunduc, Shashank Tripathi et al. · Science · 2017 · 519 citations · Full text

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin et al. · Immunity · 2020 · 376 citations · Full text

, , +8

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 342 citations · Full text

, , +10

A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

Alec W. Freyn, Jamile Ramos da Silva, Victoria Rosado et al. · Molecular Therapy · 2020 · 294 citations · Full text

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon et al. · Science · 2019 · 273 citations · Full text

Rows per page

1–5 of 70